+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Another look at Barrett's esophagus. Current thinking on screening and surveillance strategies

Another look at Barrett's esophagus. Current thinking on screening and surveillance strategies

Postgraduate Medicine 110(3): 57-8, 61-2, 65-8

Barrett's esophagus remains a major health problem and a risk factor for the development of esophageal adenocarcinoma. Given the low incidence of this disorder, efforts should be made to identify risk factors that target patients with GERD or known Barrett's esophagus who would most benefit from screening and surveillance strategies. It is clear that identifying esophageal adenocarcinoma at an early and treatable stage reduces morbidity and mortality. However, currently available screening tools (endoscopy with surveillance biopsies every 2 years) are expensive and not easily applied. Identification of tumor markers and other specific risk factors may be helpful in predicting who is at risk for dysplasia. Current therapeutic strategies are successful in the treatment of GERD symptoms, but further research and longer follow-up studies are needed to determine if these strategies bring about regression of Barrett's esophagus, reversal of dysplasia, or prevention of cancer.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 045265088

Download citation: RISBibTeXText

PMID: 11570206

DOI: 10.3810/pgm.2001.09.1018

Related references

Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Diseases of the Esophagus 21(8): 685-689, 2008

Barrett's esophagus: novel strategies for screening and surveillance. Therapeutic Advances in Chronic Disease 10: 2040622319837851, 2019

Screening and surveillance for Barrett's esophagus: current issues and future directions. Current Opinion in Gastroenterology 28(4): 377-381, 2012

Barrett esophagus Management and surveillance strategies. Practical Gastroenterology 18(9 SUPPL ): S24-S27, 1994

Screening and surveillance for Barrett esophagus. JAMA Internal Medicine 175(2): 159-160, 2015

How far to go? Screening and surveillance in Barrett's esophagus. American Journal of Managed Care 7(1 Suppl.): S19-S26, 2001

Screening And Surveillance In Barrett'S Esophagus: Much To Be Known. Evidence-Based Gastroenterology 3(3): 76-77, 2002

Screening and surveillance of Barrett's esophagus. Current Gastroenterology Reports 11(3): 195-201, 2009

Surveillance and screening for Barrett esophagus and adenocarcinoma. Journal of Clinical Gastroenterology 39(4 Suppl 2): S33-S41, 2005

Screening for and surveillance of Barrett's esophagus is clinically indicated. Digestive Diseases 25(3): 197-202, 2007

Not all of Barrett's esophagus surveillance protocols are created equal: the dangers of retrospective outcome research in the treatment of Barrett's esophagus. Gastrointestinal Endoscopy 80(6): 1203, 2015

Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies. Gut and Liver 1(2): 93-100, 2007

Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?. Digestive Diseases and Sciences 63(8): 2094-2104, 2018

Evolving screening and surveillance techniques for Barrett's esophagus. World Journal of Gastroenterology 25(17): 2045-2057, 2019

Barrett's esophagus: update on screening, surveillance, and treatment. Archives of Internal Medicine 159(13): 1411-1416, 1999